February 9, 2018

3RD Annual Innovative Approaches to Brain Tumor Management – February 9th, 2018

Our Founder, Dellann Elliott Mydland is attending today’s 3rd Annual Innovative Approaches to Brain Tumor Management Course. She will be speaking with leading experts in the field to discuss the future of brain tumor management including the progress in personalized medicine and implications of immunotherapy in specializing treatment. The design is to focus on the future of brain tumor therapy with the goal of improving treatment response rates, outcomes, and overall patient care.

Photos of 10 brain tumor specialists — Some of the amazing specialists a.k.a “Brain Tumor Rockstars” at the event

Stay tuned for updates on the results of this important meeting and to hear about our work with Dr. Kesari of the John Wayne Institute regarding developing new clinical trials for GBM patients!

Your EBCI Team!

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614

DONATE

Our Case For Change

EBCI In The News

Patient Support Services

Patient Resource Center

VOLUNTEER WITH EBCI

GET IN TOUCH

corporate partners

upcoming events

resources

About us